ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 50567 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 50567; 2) Community: the network communities that were significantly associated with the response to NSC 50567; 3) Molecule: the relationships between components within communities and NSC 50567; 4) MDR: the compounds that were significantly associated with the NSC 50567.

NSC Compound Enrichment Correlation
NSC 637126 Null 0.0415729612483928 0.017648485
NSC 637127 Null 0.0415729612483928 -0.078426757
NSC 639977 Null 0.0415729612483928 0.21254225
NSC 641319 5,12-Naphthacenedione, 10-[[3-[[5,5-di(acetyloxy)pentyl]amino]- 2,3,6-trideoxy-.alpha.-L-lyxohexopyranosyl]oxy]- 7,8,9,10-tetrahydro-6,8,11-trihydroxy- 8-(hydroxyacetyl)-1-methoxy-, hydrochloride 0.0415729612483928 -0.039505944
NSC 645210 1,4-Naphthalenedione, 2-chloro-3-[[2-(2-fluorophenyl)- 1-oxoethyl]amino]- 0.0415729612483928 0.036412619
NSC 647329 Null 0.0415729612483928 0.1286583
NSC 653147 Null 0.0415729612483928 0.082940396
NSC 654509 Pirarubicin HCl 0.0415729612483928 0.16379851
NSC 665564 Null 0.0415729612483928 0.026374123
NSC 670226 trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid 0.0415729612483928 -0.019015375
Total:67  Current:50    [First] [Prev] [Next] [Last]